Skip to content
☰ Menu
Open access · OA via Europe PMC

A 2-year Trial of Metformin to Reduce Frailty in Older Adults with Glucose Intolerance

Authors not listed

Innovation in aging · 2025

Dysbiosis Metformin
＋ Sign in to save

Abstract

This 2025 Innovation in Aging study examines a 2-year trial evaluating the use of metformin to address frailty in older adults with glucose intolerance.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
Europe PMC
Canonical
link ↗
Fetched
2026-07-01 MST

Cite this

APA
Anonymous. (2025). A 2-year Trial of Metformin to Reduce Frailty in Older Adults with Glucose Intolerance. <em>Innovation in aging</em>. https://europepmc.org/article/PMC/PMC12762609
Vancouver
Anonymous. A 2-year Trial of Metformin to Reduce Frailty in Older Adults with Glucose Intolerance. Innovation in aging. 2025.
BibTeX
@article{anon2025AyearT, title = {A 2-year Trial of Metformin to Reduce Frailty in Older Adults with Glucose Intolerance}, author = {Anonymous}, journal = {Innovation in aging}, year = {2025}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings